Stanford’s AI Breakthrough Reveals New Genetic Clues to Psychiatric Disorders

Researchers at Stanford Drugs have developed an AI-based technique to establish advanced structural variants within the human genome, revealing insights into genetic elements influencing psychiatric issues like schizophrenia and bipolar dysfunction. The research leveraged whole-genome sequencing information from over 4,000 genomes worldwide, highlighting variants in brain-related genes and areas linked to human evolution. This superior […]



Source link